Cargando…
Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology
INTRODUCTION: Labcorp’s DNA Identification division offers HLA typing at various levels of resolution using commercially available kits as well as lab developed assays. A patient sample was received by the lab requiring HLA typing for a disease association screen, and was found to have anomalous HLA...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476937/ http://dx.doi.org/10.1093/stcltm/szad047.023 |
_version_ | 1785101039209283584 |
---|---|
author | Peavy, Lydia Norvell, Brian Liu, Haipeng Steege, Eline Williams, Jon |
author_facet | Peavy, Lydia Norvell, Brian Liu, Haipeng Steege, Eline Williams, Jon |
author_sort | Peavy, Lydia |
collection | PubMed |
description | INTRODUCTION: Labcorp’s DNA Identification division offers HLA typing at various levels of resolution using commercially available kits as well as lab developed assays. A patient sample was received by the lab requiring HLA typing for a disease association screen, and was found to have anomalous HLA-A results. OBJECTIVES: To investigate a patient typing with results initially showing multiple variants to any known reference sequence. METHODS: This sample was sequenced using a lab developed whole gene assay that utilizes Pacific Biosciences’s® (PacBio) SMRT® NGS sequencing technology on a Sequel® I with LAA2 contig generation. Due to ambiguous results, the sample was repeated for confirmation using the same test, but a more sensitive data pipeline was used. Subreads coming off of the sequencer were converted to high fidelity or Closed Circular Consensus (CCS) reads using the PBAA tool from PacBio®. The sample was also processed with the GenDx NGSgo®-MX11-3 HLA typing kit with Illumina® sequencing, and the results were sent to GenDx for analysis. RESULTS: Initial testing yielded a high resolution fourth field result for HLA Class I, though the result remained ambiguous. Repeat sequencing resulted three HLA-A alleles with a similar number of CCS reads. The sample was typed as A*01:01:01:01, A*02:01:01:01, and A*02:New which contained a large exonic deletion compared to the A*02:01:01:01 reference. GenDX output confirmed previous findings, indicating a clear first allele of A*01:01:01:01, and reads for the second allele split between A*02:01:01:01 and A*02:New. DISCUSSION: Using Pacbio® sequencing technology with CCS analysis, and confirmation with GenDx technology, it was determined that this individual possesses 3 HLA-A alleles. When aligned with 02:01:01:01, both Pacbio® and GenDx assays determined the A*02:New allele to have a 34bp deletion in exon 2 (position 196-229). As a result of the frame shift caused by this deletion, a premature stop codon was found 43bp downstream from the anomaly, potentially rendering this allele null. Possible explanations for the presence of three HLA-A alleles in one patient include partial allele loss during an autoimmune event, a mutation within a chromosomal duplication of the region, or the patient has undergone a hematopoietic stem cell transplant. [Image: see text] |
format | Online Article Text |
id | pubmed-10476937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104769372023-09-05 Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology Peavy, Lydia Norvell, Brian Liu, Haipeng Steege, Eline Williams, Jon Stem Cells Transl Med Preclinical Studies INTRODUCTION: Labcorp’s DNA Identification division offers HLA typing at various levels of resolution using commercially available kits as well as lab developed assays. A patient sample was received by the lab requiring HLA typing for a disease association screen, and was found to have anomalous HLA-A results. OBJECTIVES: To investigate a patient typing with results initially showing multiple variants to any known reference sequence. METHODS: This sample was sequenced using a lab developed whole gene assay that utilizes Pacific Biosciences’s® (PacBio) SMRT® NGS sequencing technology on a Sequel® I with LAA2 contig generation. Due to ambiguous results, the sample was repeated for confirmation using the same test, but a more sensitive data pipeline was used. Subreads coming off of the sequencer were converted to high fidelity or Closed Circular Consensus (CCS) reads using the PBAA tool from PacBio®. The sample was also processed with the GenDx NGSgo®-MX11-3 HLA typing kit with Illumina® sequencing, and the results were sent to GenDx for analysis. RESULTS: Initial testing yielded a high resolution fourth field result for HLA Class I, though the result remained ambiguous. Repeat sequencing resulted three HLA-A alleles with a similar number of CCS reads. The sample was typed as A*01:01:01:01, A*02:01:01:01, and A*02:New which contained a large exonic deletion compared to the A*02:01:01:01 reference. GenDX output confirmed previous findings, indicating a clear first allele of A*01:01:01:01, and reads for the second allele split between A*02:01:01:01 and A*02:New. DISCUSSION: Using Pacbio® sequencing technology with CCS analysis, and confirmation with GenDx technology, it was determined that this individual possesses 3 HLA-A alleles. When aligned with 02:01:01:01, both Pacbio® and GenDx assays determined the A*02:New allele to have a 34bp deletion in exon 2 (position 196-229). As a result of the frame shift caused by this deletion, a premature stop codon was found 43bp downstream from the anomaly, potentially rendering this allele null. Possible explanations for the presence of three HLA-A alleles in one patient include partial allele loss during an autoimmune event, a mutation within a chromosomal duplication of the region, or the patient has undergone a hematopoietic stem cell transplant. [Image: see text] Oxford University Press 2023-09-04 /pmc/articles/PMC10476937/ http://dx.doi.org/10.1093/stcltm/szad047.023 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Preclinical Studies Peavy, Lydia Norvell, Brian Liu, Haipeng Steege, Eline Williams, Jon Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology |
title | Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology |
title_full | Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology |
title_fullStr | Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology |
title_full_unstemmed | Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology |
title_short | Abstract 22 Anomalous HLA-A Typing Found in Patient Using PacBio Sequencing Technology |
title_sort | abstract 22 anomalous hla-a typing found in patient using pacbio sequencing technology |
topic | Preclinical Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476937/ http://dx.doi.org/10.1093/stcltm/szad047.023 |
work_keys_str_mv | AT peavylydia abstract22anomaloushlaatypingfoundinpatientusingpacbiosequencingtechnology AT norvellbrian abstract22anomaloushlaatypingfoundinpatientusingpacbiosequencingtechnology AT liuhaipeng abstract22anomaloushlaatypingfoundinpatientusingpacbiosequencingtechnology AT steegeeline abstract22anomaloushlaatypingfoundinpatientusingpacbiosequencingtechnology AT williamsjon abstract22anomaloushlaatypingfoundinpatientusingpacbiosequencingtechnology |